Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions
Abstract
Share and Cite
Orlandi, C.; Conti, I.; Torre, D.; Barocci, S.; Magnani, M.; Stefanetti, G.; Casabianca, A. Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions. Vaccines 2025, 13, 1031. https://doi.org/10.3390/vaccines13101031
Orlandi C, Conti I, Torre D, Barocci S, Magnani M, Stefanetti G, Casabianca A. Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions. Vaccines. 2025; 13(10):1031. https://doi.org/10.3390/vaccines13101031
Chicago/Turabian StyleOrlandi, Chiara, Ilaria Conti, Davide Torre, Simone Barocci, Mauro Magnani, Giuseppe Stefanetti, and Anna Casabianca. 2025. "Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions" Vaccines 13, no. 10: 1031. https://doi.org/10.3390/vaccines13101031
APA StyleOrlandi, C., Conti, I., Torre, D., Barocci, S., Magnani, M., Stefanetti, G., & Casabianca, A. (2025). Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions. Vaccines, 13(10), 1031. https://doi.org/10.3390/vaccines13101031